Inspiration Healthcare Group PLC
LSE:IHC
Inspiration Healthcare Group PLC
Inspiration Healthcare Group Plc engages in the provision of medical technology for critical care, operating theatre, and other medical applications. The company is headquartered in Crawley, West Sussex and currently employs 149 full-time employees. The company went IPO on 2001-12-14. The company provides products to patients around the world, which help to improve patient outcomes, and it invests in product opportunities and disruptive technologies. The company operates through its three subsidiaries, Inspiration Healthcare Ltd, SLE Ltd and Viomedex Ltd. Under these brands it sells neonatal intensive care and operating theatre equipment around the world through a network of distributors into approximately 75 countries. The company also acts as a distributor for third party companies, which want to access the United Kingdom and the Republic of Ireland’s health systems using its sales and service of these healthcare providers. The company distributes its products to the various therapy areas, including infusion, respiratory and developmental care. The company operates through a single business segment, Critical Care Medical Devices.
Inspiration Healthcare Group Plc engages in the provision of medical technology for critical care, operating theatre, and other medical applications. The company is headquartered in Crawley, West Sussex and currently employs 149 full-time employees. The company went IPO on 2001-12-14. The company provides products to patients around the world, which help to improve patient outcomes, and it invests in product opportunities and disruptive technologies. The company operates through its three subsidiaries, Inspiration Healthcare Ltd, SLE Ltd and Viomedex Ltd. Under these brands it sells neonatal intensive care and operating theatre equipment around the world through a network of distributors into approximately 75 countries. The company also acts as a distributor for third party companies, which want to access the United Kingdom and the Republic of Ireland’s health systems using its sales and service of these healthcare providers. The company distributes its products to the various therapy areas, including infusion, respiratory and developmental care. The company operates through a single business segment, Critical Care Medical Devices.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
